POZEN INC /NC (POZN) financial statements (2021 and earlier)

Company profile

Business Address 1414 RALEIGH ROAD
CHAPEL HILL, NC 27517
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments37424443383227
Cash and cash equivalents37424441363227
Short-term investments   32  
Receivables6546655
Other undisclosed current assets0011101
Total current assets:43474949453832
Noncurrent Assets
Property, plant and equipment0000000
Other undisclosed noncurrent assets   1   
Total noncurrent assets:0001000
TOTAL ASSETS:43474950453832
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities131123332
Accounts payable1101000
Accrued liabilities5410111
Employee-related liabilities7612221
Deferred revenue and credits(0)000468
Deferred tax liabilities   1   
Other undisclosed current liabilities0(0)(0)(0)   
Total current liabilities:1311247911
Noncurrent Liabilities
Liabilities, other than long-term debt   1000
Deferred revenue and credits    000
Deferred tax liabilities, net   1   
Other undisclosed noncurrent liabilities11     
Total noncurrent liabilities:11 1000
Total liabilities:1412257911
Stockholders' equity
Stockholders' equity attributable to parent29354747382922
Common stock0000000
Additional paid in capital150148144144142139135
Accumulated deficit(121)(113)(97)(97)(104)(111)(114)
Total stockholders' equity:29354747382922
Other undisclosed liabilities and equity   (1)(0)(0)(0)
TOTAL LIABILITIES AND EQUITY:43474950453832

Income statement (P&L) ($ in millions)

9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
Revenue, net12109 13138
Gross profit:121091513138
Operating expenses(14)(20)(4)(3)(4)(4)(5)
Operating income (loss):(2)(10)512983
Nonoperating income (expense)
(Investment Income, Nonoperating)
00(0)0300
Other undisclosed loss from continuing operations before equity method investments, income taxes(6)(5)(4)(45)(5)(5) 
Income (loss) from continuing operations before income taxes:(8)(15)(0)(32)733
Income tax expense (benefit)0(1)     
Net income (loss):(8)(16)(0)(32)733
Other undisclosed net income attributable to parent   39   
Net income (loss) available to common stockholders, diluted:(8)(16)(0)7733

Comprehensive Income ($ in millions)

9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
Net income (loss):(8)(16)(0)(32)733
Comprehensive income (loss):(8)(16)(0)(32)733
Other undisclosed comprehensive income, net of tax, attributable to parent   39   
Comprehensive income (loss), net of tax, attributable to parent:(8)(16)(0)7733

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: